(Q36008535)

11 August 2017

1 reference

title

The art and science of risk management: a US research-based industry perspective (English)

1 reference

11 August 2017

Janice K Bush

1

1 reference

11 August 2017

Wanju S Dai

2

1 reference

11 August 2017

Gretchen S Dieck

3

1 reference

11 August 2017

Linda S Hostelley

4

1 reference

11 August 2017

Thomas Hassall

5

1 reference

11 August 2017

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

28

1 reference

11 August 2017

1-18

1 reference

11 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200528010-00001

11 August 2017

0 references

cites work

The UK General Practice Research Database

1 reference

12 December 2020

Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety

1 reference

12 December 2020

A novel scheme for the reporting of adverse drug reactions

1 reference

12 December 2020

An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians

1 reference

12 December 2020

Direct-to-consumer advertising--strengthening our health care system

1 reference

12 December 2020

A Bayesian neural network method for adverse drug reaction signal generation.

1 reference

12 December 2020

Use of the UK General Practice Research Database for pharmacoepidemiology

1 reference

12 December 2020

Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity

1 reference

12 December 2020

The management of adverse drug reactions: from diagnosis to signal.

1 reference

12 December 2020

Signal generation and clarification: use of case-control data.

1 reference

12 December 2020

[A new system for drug control in the EEC. Role of Sweden in an active monitoring of adverse effects]

1 reference

12 December 2020

US adverse drug reaction surveillance 1989-1994

1 reference

12 December 2020

Serious cardiovascular events and mortality among patients with schizophrenia

1 reference

12 December 2020

Bar code label requirement for human drug products and biological products. Final rule

1 reference

12 December 2020

Human drug metabolism and the cytochromes P450: application and relevance of in vitro models

1 reference

12 December 2020

Pushing ethical pharmaceuticals direct to the public

1 reference

12 December 2020

The ambiguity of adverse drug reactions

1 reference

12 December 2020

Accuracy of hepatic adverse drug reaction reporting in one English health region

1 reference

12 December 2020

Adverse drug reactions: physicians' opinions versus a causality assessment method

1 reference

12 December 2020

Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events

1 reference

12 December 2020

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data

1 reference

12 December 2020

The New Zealand intensive medicines monitoring programme in pro-active safety surveillance

1 reference

12 December 2020

Availability of primary care providers and pharmacists in the United States.

1 reference

12 December 2020

The nurses' health study: a cohort of US women followed since 1976

1 reference

12 December 2020

Contraindicated use of cisapride: impact of food and drug administration regulatory action

1 reference

12 December 2020

Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery

1 reference

12 December 2020

The incident reporting system does not detect adverse drug events: a problem for quality improvement.

1 reference

12 December 2020

Use of an algorithm to evaluate published reports of adverse drug reactions

1 reference

12 December 2020

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

1 reference

12 December 2020

Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems

1 reference

12 December 2020

Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada.

1 reference

12 December 2020

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

1 reference

12 December 2020

Post-marketing studies: the work of the Drug Safety Research Unit

1 reference

12 December 2020

Patient safety and computerized medication ordering at Brigham and Women's Hospital

1 reference

12 December 2020

Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems

1 reference

12 December 2020

International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice

1 reference

12 December 2020

Rhode Island physicians' recognition and reporting of adverse drug reactions

1 reference

12 December 2020

Adverse drug reactions—a matter of opinion

1 reference

12 December 2020

Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.

1 reference

12 December 2020

Drug target pharmacogenomics: an overview

1 reference

12 December 2020

Direct-to-Consumer Advertising — Education or Emotion Promotion?

1 reference

12 December 2020

Effect of computerized physician order entry and a team intervention on prevention of serious medication errors

1 reference

12 December 2020

Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions

1 reference

12 December 2020

Limitations and strengths of spontaneous reports data

1 reference

12 December 2020

Postmarketing safety information: how useful are spontaneous reports?

1 reference

12 December 2020

10.2165/00002018-200528010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference